home / stock / exai / exai news


EXAI News and Press, Exscientia Limited From 11/09/23

Stock Information

Company Name: Exscientia Limited
Stock Symbol: EXAI
Market: NASDAQ
Website: exscientia.ai

Menu

EXAI EXAI Quote EXAI Short EXAI News EXAI Articles EXAI Message Board
Get EXAI Alerts

News, Short Squeeze, Breakout and More Instantly...

EXAI - Expected US Company Earnings on Thursday, November 9th, 2023

Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...

EXAI - Expected earnings - Exscientia Plc

Exscientia Plc (EXAI) is expected to report $-0.42 for Q3 2023

EXAI - Exscientia to Report Third Quarter 2023 Financial Results on November 9, 2023

Company to host conference call and webcast on November 9, 2023, at 1:30 p.m. GMT / 8:30 a.m. EST Exscientia plc (Nasdaq: EXAI) will report financial results for the third quarter ended September 30, 2023, on Thursday, November 9, 2023, before the open of U.S. markets. The Company will ...

EXAI - Parker Moss to Join Exscientia as EVP, Corporate Development

Renowned technology champion to strengthen company’s development of precision medicine and clinical innovation platforms Exscientia plc (Nasdaq: EXAI) today announced the appointment of Parker Moss as Executive Vice President, Corporate Development, effective January, 2024. In th...

EXAI - Exscientia to Present New Preclinical Data for AI-designed LSD1 and MALT1 Inhibitors at ESMO 2023

— Demonstrated preclinical efficacy of LSD1 inhibitor in primary AML samples — — Initial data supporting combination potential of LSD1 inhibitor with AML standard of care therapies — — Tumour growth inhibition through MALT1 in monotherapy and com...

EXAI - Phio Pharmaceuticals, Exscientia among healthcare movers

2023-10-11 10:00:00 ET More on Health Care Select Sector SPDR BofA reports 10th consecutive week of equity inflows Citi turns cautious on pharmaceuticals and biotech Seeking Alpha’s Quant Rating on Health Care Select Sector SPDR For further details see...

EXAI - Exscientia Details Pipeline Prioritisation Strategy

Concentrating rapidly emerging pipeline on most differentiated, highest value oncology targets, including CDK7 and LSD1 programmes Partnering or discontinuing internal development of programmes outside of core focus, including A 2A and select discovery targets Strategy will su...

EXAI - Exscientia: Merck Deal Further Cements Industry Positioning, Reiterate Buy

2023-09-20 14:02:43 ET Summary Exscientia plc has partnered with Merck KGaA for AI-powered drug discovery in complex disease segments, solidifying its industry positioning. AI is gaining traction in the healthcare industry, with projections estimating the AI drug discovery market ...

EXAI - 24/7 Market News Lunch Break 20 Sept 2023

2023-09-20 12:27:59 ET DENVER, Colo., Sept 20, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Genius Group (NYSEAMERICAN:GNS), Steelcase (NYSE:SCS), Fresh Tracks Therapeutics (NASDAQ:FRTX), Exscie...

EXAI - 24/7 Market News Snapshot 20 Sept 2023

2023-09-20 10:11:33 ET DENVER, Colo., Sept 20, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Genius Group (NYSEAMERICAN:GNS), Steelcase (NYSE:SCS), Fresh Tracks Therapeutics (NASDAQ:FRTX), Exscientia (N...

Previous 10 Next 10